Sysmex ADR Operating Margin 2016-2024 | SSMXY
Sysmex ADR Operating Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM Operating Income | Operating Margin |
2024-06-30 | $2.80B | $0.43B | 15.24% |
2023-06-30 | $2.64B | $0.38B | 14.53% |
2022-06-30 | $2.57B | $0.39B | 15.17% |
2021-06-30 | $2.52B | $0.43B | 17.17% |
2020-06-30 | $2.35B | $0.41B | 17.33% |
2019-06-30 | $2.34B | $0.47B | 20.16% |
2018-06-30 | $2.30B | $0.95B | 41.49% |
2017-06-30 | $2.21B | $1.35B | 60.98% |
2016-06-30 | $2.19B | $1.76B | 80.73% |
2016-03-31 | $2.11B | $2.11B | 100.00% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | MED INSTRUMENTS | $11.545B | $3.197B |
Sysmex Corporation is engaged in the development, manufacture, import, export and sale of clinical laboratory instruments, reagents and software used in -vitro diagnostics. It also provides clinical laboratory testing of blood, urine and other specimens. The company's product includes instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis and point-of-care testing. Its operating segment consists of Japan, Americas, EMEA, China and Asia Pacific. Sysmex Corporation is headquartered in Kobe, Japan. |